{"id":"https://openalex.org/W2008331326","doi":"https://doi.org/10.1592/phco.31.4.439","title":"Therapeutic Drug Monitoring in Patients Coinfected with Human Immunodeficiency Virus and Disseminated Mycobacterium avium Complex","display_name":"Therapeutic Drug Monitoring in Patients Coinfected with Human Immunodeficiency Virus and Disseminated Mycobacterium avium Complex","publication_year":2011,"publication_date":"2011-03-25","ids":{"openalex":"https://openalex.org/W2008331326","doi":"https://doi.org/10.1592/phco.31.4.439","mag":"2008331326"},"language":"en","primary_location":{"id":"doi:10.1592/phco.31.4.439","doi":"https://doi.org/10.1592/phco.31.4.439","is_oa":false,"landing_page_url":"https://doi.org/10.1592/phco.31.4.439","pdf_url":null,"source":{"id":"https://openalex.org/S122731057","display_name":"Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy","issn_l":"0277-0008","issn":["0277-0008","1875-9114"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5103878695","display_name":"Keith J. Dunn","orcid":"https://orcid.org/0009-0009-9904-7186","observed_orcids":["https://orcid.org/0009-0009-9904-7186"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Keith J. Dunn","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091652325","display_name":"Paul R. Skolnik","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Paul R. Skolnik","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027608003","display_name":"Leyla Azis","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Leyla Azis","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5112533556","display_name":"H\u00e9l\u00e8ne Hardy","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Helene Hardy","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4030,"currency":"USD","value_usd":4030},"apc_paid":null,"fwci":0.2397,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.62263251,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":94},"biblio":{"volume":"31","issue":"4","first_page":"439","last_page":"439"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11316","display_name":"Mycobacterium research and diagnosis","score":0.7559000253677368,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11316","display_name":"Mycobacterium research and diagnosis","score":0.7559000253677368,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.1835000067949295,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11381","display_name":"Infectious Diseases and Tuberculosis","score":0.010300000198185444,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/therapeutic-drug-monitoring","display_name":"therapeutic drug monitoring","score":0.9380000233650208},{"id":"https://openalex.org/keywords/hiv-coinfection","display_name":"HIV coinfection","score":0.871999979019165},{"id":"https://openalex.org/keywords/rifabutin","display_name":"rifabutin","score":0.9390000104904175},{"id":"https://openalex.org/keywords/drug-interactions","display_name":"drug interactions","score":0.7039999961853027},{"id":"https://openalex.org/keywords/atazanavir","display_name":"atazanavir","score":0.8849999904632568},{"id":"https://openalex.org/keywords/ritonavir","display_name":"ritonavir","score":0.9100000262260437},{"id":"https://openalex.org/keywords/protease-inhibitors","display_name":"protease inhibitors","score":0.7350000143051147},{"id":"https://openalex.org/keywords/clarithromycin","display_name":"clarithromycin","score":0.8849999904632568},{"id":"https://openalex.org/keywords/ethambutol","display_name":"ethambutol","score":0.9449999928474426},{"id":"https://openalex.org/keywords/ciprofloxacin","display_name":"ciprofloxacin","score":0.9879999756813049},{"id":"https://openalex.org/keywords/dose-adjustment","display_name":"dose adjustment","score":0.5979999899864197},{"id":"https://openalex.org/keywords/opportunistic-infections","display_name":"opportunistic infections","score":0.6159999966621399}],"concepts":[{"id":"https://openalex.org/C2780867798","wikidata":"https://www.wikidata.org/wiki/Q1135705","display_name":"Rifabutin","level":4,"score":0.9776099920272827},{"id":"https://openalex.org/C2779298103","wikidata":"https://www.wikidata.org/wiki/Q422618","display_name":"Ritonavir","level":5,"score":0.8837870955467224},{"id":"https://openalex.org/C2778414717","wikidata":"https://www.wikidata.org/wiki/Q423467","display_name":"Atazanavir","level":5,"score":0.8079391121864319},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7103769779205322},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.5647031664848328},{"id":"https://openalex.org/C2776228421","wikidata":"https://www.wikidata.org/wiki/Q412318","display_name":"Ethambutol","level":4,"score":0.5263936519622803},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4968889057636261},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.46644115447998047},{"id":"https://openalex.org/C2781143361","wikidata":"https://www.wikidata.org/wiki/Q55761529","display_name":"Protease inhibitor (pharmacology)","level":5,"score":0.42669716477394104},{"id":"https://openalex.org/C2777182164","wikidata":"https://www.wikidata.org/wiki/Q422585","display_name":"Lopinavir","level":5,"score":0.41610831022262573},{"id":"https://openalex.org/C2776962512","wikidata":"https://www.wikidata.org/wiki/Q118551","display_name":"Clarithromycin","level":3,"score":0.3686775863170624},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3593624234199524},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.31485068798065186},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.27392858266830444},{"id":"https://openalex.org/C142462285","wikidata":"https://www.wikidata.org/wiki/Q2528140","display_name":"Viral load","level":3,"score":0.24309489130973816},{"id":"https://openalex.org/C2993143319","wikidata":"https://www.wikidata.org/wiki/Q583050","display_name":"Antiretroviral therapy","level":4,"score":0.1782270073890686},{"id":"https://openalex.org/C2778607973","wikidata":"https://www.wikidata.org/wiki/Q422652","display_name":"Rifampicin","level":3,"score":0.15147244930267334},{"id":"https://openalex.org/C2781069245","wikidata":"https://www.wikidata.org/wiki/Q12204","display_name":"Tuberculosis","level":2,"score":0.12357315421104431},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.09145554900169373},{"id":"https://openalex.org/C2776409635","wikidata":"https://www.wikidata.org/wiki/Q180556","display_name":"Helicobacter pylori","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1592/phco.31.4.439","doi":"https://doi.org/10.1592/phco.31.4.439","is_oa":false,"landing_page_url":"https://doi.org/10.1592/phco.31.4.439","pdf_url":null,"source":{"id":"https://openalex.org/S122731057","display_name":"Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy","issn_l":"0277-0008","issn":["0277-0008","1875-9114"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/case-report","display_name":"Case Report"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2136456235","https://openalex.org/W2320841219","https://openalex.org/W2049831952","https://openalex.org/W2101668399","https://openalex.org/W2317698849","https://openalex.org/W2163947037","https://openalex.org/W2090099730","https://openalex.org/W2046797497","https://openalex.org/W2139343988","https://openalex.org/W2415783346"],"abstract_inverted_index":{"In":[0],"patients":[1,184,195,221],"infected":[2],"with":[3,28,67,185],"human":[4],"immunodeficiency":[5,18],"virus":[6],"(HIV),":[7],"antiretroviral":[8,86,111],"therapy":[9,42,112],"has":[10],"decreased":[11],"the":[12,33,53,58,149,189],"risk":[13],"of":[14,37,92,114,151,192],"progression":[15],"to":[16,44,56,155,215],"acquired":[17],"syndrome":[19],"or":[20],"death":[21],"significantly.":[22],"However,":[23],"many":[24],"individuals":[25],"still":[26],"present":[27],"an":[29],"opportunistic":[30,59],"infection":[31],"as":[32,202],"first":[34],"clinical":[35],"manifestation":[36],"HIV":[38,68,186],"infection.":[39,60,187],"This":[40],"complicates":[41],"due":[43],"frequent":[45],"and":[46,52,69,105,121,175,179],"complex":[47,73,178],"drug":[48],"interactions":[49,172],"between":[50,173],"antiretrovirals":[51,174],"drugs":[54,224],"used":[55],"treat":[57],"We":[61],"describe":[62],"a":[63,197],"48\u2010year\u2010old":[64],"man":[65],"coinfected":[66],"disseminated":[70],"Mycobacterium":[71],"avium":[72],"(MAC).":[74],"His":[75,110],"treatment":[76],"for":[77],"MAC":[78,89],"started":[79,85],"about":[80],"2":[81],"weeks":[82],"before":[83],"he":[84],"therapy.":[87],"The":[88],"regimen":[90],"consisted":[91,113],"clarithromycin":[93],"500":[94,107],"mg/day,":[95,98,117,120],"ethambutol":[96],"1200":[97],"rifabutin":[99,136,152,165,193,218],"150":[100,205],"mg":[101,108,157,206],"every":[102,158,207],"other":[103,159,208],"day,":[104,209],"ciprofloxacin":[106],"twice/day.":[109],"atazanavir":[115],"300":[116,125,156],"ritonavir":[118],"100":[119],"emtricitabine":[122],"200":[123],"mg\u2010tenofovir":[124],"mg/day.":[126],"Approximately":[127],"95":[128],"days":[129,162],"after":[130],"receiving":[131,196,222],"these":[132,223],"concomitant":[133],"therapies,":[134],"his":[135,164],"peak":[137,143,166],"concentration":[138,144,167],"was":[139,153,168],"0.08":[140],"\u03bcg/ml":[141],"(goal":[142],">":[145],"0.45":[146],"\u03bcg/ml);":[147],"thus,":[148],"dosage":[150,191],"increased":[154],"day.":[160],"Fourteen":[161],"later,":[163],"0.43":[169],"\u03bcg/ml.":[170],"Drug":[171],"antimycobacterials":[176],"are":[177],"not":[180],"fully":[181],"understood":[182],"in":[183,194,220],"Although":[188],"recommended":[190],"ritonavir\u2010boosted":[198],"protease":[199],"inhibitor,":[200],"such":[201],"atazanavir,":[203],"is":[204],"higher":[210],"dosages":[211],"may":[212],"be":[213],"required":[214],"attain":[216],"optimal":[217],"concentrations":[219],"concomitantly.":[225]},"counts_by_year":[{"year":2012,"cited_by_count":1}],"updated_date":"2026-09-26T08:19:03.415552","created_date":"2016-06-24T00:00:00"}